The EMA's human medicines committee has started a review of oral complement C5 inhibitor Tavneos, prompted by information that the regulator says raises questions about the integrity of the data from ...

The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use has started a review of avacopan (Tavneos, Amgen), a drug authorized in the EU for treating adults with severe, ...

The Ethereum price is entering February 2026 at a critical crossroads. After losing nearly 7% in January, ETH is closing the month in clear contrast to its historical trend. January’s median return ...

Bitcoin tests $88,000 support as investors navigate weak sentiment amid macroeconomic pressure. Ethereum slides below $3,000 but stays above $2,900 support as ETFs post inflows totaling $28 million on ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

The Sandbox extends gains on Wednesday after rebounding from the 50-day EMA at $0.134 the previous day. On-chain data and derivatives point to a bullish picture, with whales accumulating SAND and open ...

Analysts say Bitcoin’s volatile price action reflects an increasing risk of distribution as new BTC whales dominate short-term flows. Is a drop to $85,000 in play for the short term? New BTC whales ...

XRP price gained in the first five days of 2026 as chart breakouts and steady ETF inflows produced targets near $3, with longer-term projections as high as $7-$8. XRP’s technical setup is turning ...

XRP slipped to $1.85 after breaking the $1.87 support zone, with heavier exchange inflows pointing to renewed distribution just as bitcoin’s rebound lost momentum and broader risk appetite stayed ...

A novel non-antibiotic approach to diarrhea treatment is important because there are no FDA-approved drugs to treat general diarrhea in dogs, the second most common reason for visits to veterinary ...